Literature DB >> 5722744

48,XXXX-49,XXXXX mosaic: asynchronies among the late-replicating X chromosomes.

N Ricci, B Dallapiccola, B Ventimiglia, L Tiepolo, M Fraccaro.   

Abstract

Mesh：

Year:  1968        PMID： 5722744     DOI： 10.1159/000129989

Source DB:  PubMed          Journal:  Cytogenetics        ISSN： 0011-4537


× No keyword cloud information.
  8 in total

1.  BrdU-33258 Hoechst analysis of DNA replication in human lymphocytes with supernumerary or structurally abnormal X chromosomes.

Authors:  S A Latt; H F Willard; P S Gerald
Journal:  Chromosoma       Date:  1976-08-17       Impact factor: 4.316

2.  Comparative clinical studies and X chromosome behaviour in a case of XXXX-XXXXX mosaicism.

Authors:  P Cooke; J A Black; D J Curtis
Journal:  J Med Genet       Date:  1972-06       Impact factor: 6.318

3.  The position of chromosomes at metaphase in human fibroblasts and their DNA synthesis behaviour.

Authors:  C H Ockey
Journal:  Chromosoma       Date:  1969       Impact factor: 4.316

4.  The triplo-X female: an appraisal based on a study of 12 cases and a review of the literature.

Authors:  M L Barr; F R Sergovich; D H Carr; E L Saver
Journal:  Can Med Assoc J       Date:  1969-09-06       Impact factor: 8.262

5.  Tetrasomy and pentasomy of the X chromosome.

Authors:  Edith Schoubben; Karin Decaestecker; Koen Quaegebeur; Lode Danneels; Geert Mortier; Luc Cornette
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

6.  X pentasomy: a case and review.

Authors:  N Archidiacono; M Rocchi; M Valente; G Filippi
Journal:  Hum Genet       Date:  1979-11-01       Impact factor: 4.132

7.  The penta-X syndrome.

Authors:  A Monheit; U Francke; B Saunders; K L Jones
Journal:  J Med Genet       Date:  1980-10       Impact factor: 6.318

8.  Detailed analysis of X chromosome inactivation in a 49,XXXXX pentasomy.

Authors:  Lucia M Moraes; Leila Ca Cardoso; Vera Ls Moura; Miguel Am Moreira; Albert N Menezes; Juan C Llerena; Héctor N Seuánez
Journal:  Mol Cytogenet       Date:  2009-10-07       Impact factor: 2.009
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.